Q - USANA HEALTH SCIENCES
For the period ended Jun 28, 2025. Filed Aug 5, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 28, 2025 · Filed Aug 5, 2025
USNA$13.85+1.6%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets
(in thousands, except par value)
| As ofJune 28,2025 | As ofDecember 28, 2024 | |
|---|---|---|
| ASSETS | ||
| Current assets | ||
| Cash and cash equivalents | $151,338 | $181,768 |
| Inventories | 83,269 | 69,735 |
| Prepaid expenses and other current assets | 27,259 | 27,684 |
| Total current assets | 261,866 | 279,187 |
| Property and equipment, net | 96,532 | 94,565 |
| Goodwill | 144,230 | 144,168 |
| Intangible assets, net | 142,747 | 151,823 |
| Deferred tax assets | 26,435 | 19,644 |
| Other assets | 62,716 | 58,806 |
| Total assets | $734,526 | $748,193 |
| LIABILITIES, REDEEMABLE NONCONTROLLING INTEREST, AND STOCKHOLDERS' EQUITY | ||
| Current liabilities | ||
| Accounts payable | $17,899 | $11,984 |
| Line of credit | — | 23,000 |
| Other current liabilities | 103,726 | 104,641 |
| Total current liabilities | 121,625 | 139,625 |
| Deferred tax liabilities | 4,662 | 4,073 |
| Other long-term liabilities | 22,681 | 18,163 |
| Total liabilities | 148,968 | 161,861 |
| Redeemable noncontrolling interest | 54,498 | 54,223 |
| Stockholders' equity | ||
| Common stock, $0.001 par value; Authorized -- 50,000 shares, issued and outstanding 18,262 as of June 28, 2025 and 19,064 as of December 28, 2024 | 18 | 19 |
| Additional paid-in capital | 76,374 | 75,816 |
| Retained earnings | 474,017 | 478,944 |
| Accumulated other comprehensive income (loss) | (19,349) | (22,670) |
| Total stockholders' equity attributable to USANA | 531,060 | 532,109 |
| Total liabilities, redeemable noncontrolling interest, and stockholders' equity | $734,526 | $748,193 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.